Adam F Steinlauf, MD Email Adam Steinlauf
- SENIOR FACULTY | Medicine, Gastroenterology
- Hospital Affiliations
- Mount Sinai St. Luke's and Mount Sinai West
- The Mount Sinai Hospital
- Feinstein IBD Clinical Center 212-241-8100212-241-8100
Dr. Steinlauf received his B.A. from Brandeis University. He graduated Cum Laude in 1987 and was elected to the Phi Beta Kappa honor society. He received his medical degree from the State University of New York Health Science Center at Brooklyn (Downstate Medical School), and graduated Cum Laude in 1991. He received his residency training in the department of Internal Medicine at Columbia-Presbyterian Medical Center from 1991-1994. After completing his residency training, he was appointed Assistant Clinical Professor of Medicine at Columbia University School of Medicine and Assistant Attending, Columbia-Presbyterian Medical Center from 1994-1995 where he practiced Internal Medicine. He then received his Gastroenterology fellowship training at Yale University from 1995-1998. From 1998-2001, Dr. Steinlauf was in private practice in New Jersey, and in 2001, he joined the gastroenterology practice of Drs. Daniel Present, Mark Chapman, and James Marion.
Dr. Steinlauf is fully trained in all aspects of gastroenterology but subspecializes in the diagnosis and treatment of the inflammatory bowel diseases (IBD), ulcerative colitis and Crohn's disease. In addition, Dr. Steinlauf is extensively involved in the study of new and exciting research protocols which will hopefully lead to a better understanding of IBD and improve on current management strategies.
- Colon Polypectomy
- Colon Polyps
- Crohn's Disease
- Flexible Sigmoidoscopy
- Inflammatory Bowel Disease
- Iron-Deficiency Anemia
- Irritable Bowel Syndrome
- Peptic Ulcer
- Short Bowel Syndrome
- Ulcerative Colitis
- Upper GI Endoscopy
MD, S.U.N.Y., Health Science Center
Internship, Internal Medicine
Residency, Internal Medicine
Columbia-Presbyterian Medical Ctr.
Yale-New Haven Hospital
Current protocols in progress for Ulcerative Colitis include: Rosiglitazone, the probiotic VSL#3, Visilizumab, and Luekocytapharesis.
Current protocols for in progress for Crohn -?s disease include: extracorporeal photoimmune therapy with UVADEX, Sargrostim (Leukine), anti-IL-12, Adalimumab, Visilizumab and high dose asacol.
Steinlauf AF, Traube M. Esophageal Reflux and Anesthetic Risk: Proton Pump Inhibitors and Other New Agents. Anesthesiol Clin North America: Annual of Anesthetic Pharmacology 1998;(2): 17-36.
Steinlauf AF, Traube M, Neitlich JD, Cooney EL. Clostridium difficile Colitis: A Possible Cause of Unexplained Elevation of Serum Alkaline Phosphatase Levels in Patients with AIDS. Clin Infect Dis 1998 May; 26(5): 1248-9.
Steinlauf AF, Garcia-Tsao G, Zakko MF, Dickey K, Gupta T, Groszmann RJ. Low Dose Midazolam Sedation: An Option For Patients Undergoing Serial Hepatic Venous Pressure Measurements. Hepatology 1999 Apr; 29(4): 1070-3.
Steinlauf AF, Chan PK, Traube M. Gastrointestinal Complications. In: Burrow GN, Duffy TP, Copel JA, editors. Medical Complications During Pregnancy. 6th ed. Philadelphia, W.B. Saunders Co.; 2004. pp259-278.
Steinlauf AF, Present DH. Medical Management of the Pregnant Patient with Inflammatory Bowel Disease. Gastroenterol Clin North Am. 2004 Jun; 33(2): 361-85.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Steinlauf did not report having any of the following types of financial relationships with industry during 2017 and/or 2018: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.